189 related articles for article (PubMed ID: 8797597)
1. Differential and antagonistic effects of v-Jun and c-Jun.
Gao M; Morgan I; Vogt PK
Cancer Res; 1996 Sep; 56(18):4229-35. PubMed ID: 8797597
[TBL] [Abstract][Full Text] [Related]
2. v-Jun represses c-jun proto-oncogene expression in vivo through a 12-O-tetradecanoylphorbol-13-acetate-responsive element in the proximal gene promoter.
Hussain S; Kilbey A; Gillespie DA
Cell Growth Differ; 1998 Aug; 9(8):677-86. PubMed ID: 9716184
[TBL] [Abstract][Full Text] [Related]
3. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences.
Hadman M; Loo M; Bos TJ
Oncogene; 1993 Jul; 8(7):1895-903. PubMed ID: 8510933
[TBL] [Abstract][Full Text] [Related]
4. Structure and transcriptional regulation of BKJ, a novel AP-1 target gene activated during jun- or fos-induced fibroblast transformation.
Hartl M; Bister K
Oncogene; 1998 Dec; 17(22):2901-13. PubMed ID: 9879996
[TBL] [Abstract][Full Text] [Related]
5. Directed mutation of the basic domain of v-Jun alters DNA binding specificity and abolishes its oncogenic activity in chicken embryo fibroblasts.
Basso J; Briggs J; Findlay C; Bos T
Oncogene; 2000 Oct; 19(42):4876-85. PubMed ID: 11039905
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of intercellular adhesion molecule 1 by phorbol ester in human neuroblastoma cell line SK-N-SH involves jun- and fos-containing activator protein 1 site binding complex(es).
Farina AR; Cappabianca L; Mackay AR; Tiberio A; Tacconelli A; Tessitore A; Frati L; Martinotti S; Gulino A
Cell Growth Differ; 1997 Jul; 8(7):789-800. PubMed ID: 9218873
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell leukemia virus type 1 tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells.
Iwai K; Mori N; Oie M; Yamamoto N; Fujii M
Virology; 2001 Jan; 279(1):38-46. PubMed ID: 11145887
[TBL] [Abstract][Full Text] [Related]
8. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction.
Kilbey A; Black EJ; Unlu M; Gillespie DA
Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782
[TBL] [Abstract][Full Text] [Related]
9. v-Jun downregulates the SPARC target gene by binding to the proximal promoter indirectly through Sp1/3.
Chamboredon S; Briggs J; Vial E; Hurault J; Galvagni F; Oliviero S; Bos T; Castellazzi M
Oncogene; 2003 Jun; 22(26):4047-61. PubMed ID: 12821939
[TBL] [Abstract][Full Text] [Related]
10. Impaired induction of c-fos/c-jun genes and of transcriptional regulatory proteins binding distinct c-fos/c-jun promoter elements in activated human T cells during aging.
Whisler RL; Chen M; Beiqing L; Carle KW
Cell Immunol; 1997 Jan; 175(1):41-50. PubMed ID: 9015187
[TBL] [Abstract][Full Text] [Related]
11. TOJ3, a target of the v-Jun transcription factor, encodes a protein with transforming activity related to human microspherule protein 1 (MCRS1).
Bader AG; Schneider ML; Bister K; Hartl M
Oncogene; 2001 Nov; 20(51):7524-35. PubMed ID: 11709724
[TBL] [Abstract][Full Text] [Related]
12. Isolation of novel, transcriptionally active AP-1 binding sites: implications for cellular transformation.
Hawker KL; Vass JK; Ozanne BW
Oncogene; 1996 Jul; 13(2):283-92. PubMed ID: 8710367
[TBL] [Abstract][Full Text] [Related]
13. Occupancy and composition of proteins bound to the AP-1 sites in the glucocorticoid receptor and c-jun promoters after glucocorticoid treatment and in different cell types.
Barrett TJ; Vedeckis WV
Recept Signal Transduct; 1996; 6(3-4):179-93. PubMed ID: 9259052
[TBL] [Abstract][Full Text] [Related]
14. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos.
Echlin DR; Tae HJ; Mitin N; Taparowsky EJ
Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209
[TBL] [Abstract][Full Text] [Related]
15. Regulation of IL-1-induced gingival collagenase gene expression by activator protein-1 (c-Fos/c-Jun).
Hamid QA; Reddy PJ; Tewari M; Uematsu S; Tuncay OC; Tewari DS
Cytokine; 2000 Nov; 12(11):1609-19. PubMed ID: 11052811
[TBL] [Abstract][Full Text] [Related]
16. JAC, a direct target of oncogenic transcription factor Jun, is involved in cell transformation and tumorigenesis.
Hartl M; Reiter F; Bader AG; Castellazzi M; Bister K
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13601-6. PubMed ID: 11698665
[TBL] [Abstract][Full Text] [Related]
17. Selective activation of the proto-oncogene c-jun promoter by the transforming protein v-Rel.
Fujii M; Minamino T; Nomura M; Miyamoto KI; Tanaka J; Seiki M
Oncogene; 1996 May; 12(10):2193-202. PubMed ID: 8668346
[TBL] [Abstract][Full Text] [Related]
18. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
19. Activation of Jun/AP-1 by protein kinase A.
de Groot RP; Sassone-Corsi P
Oncogene; 1992 Nov; 7(11):2281-6. PubMed ID: 1331936
[TBL] [Abstract][Full Text] [Related]
20. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
Neuveut C; Vigne R; Clements JE; Sire J
Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
